Senores PharmaceuticalsNSE:SENORES -0.39%18 Operating Margin % is 21.80% as of Mar. 2026, which is 19% above its 10-year median of 18.30. GuruFocus rates NSE:SENORES with a GF Score™ of 18/100. The stock has 7 warning signs investors should review. Among 955 Drug Manufacturers companies, Senores Pharmaceuticals ranks better than 89.74% on this metric.
The historical rank and industry rank for Senores Pharmaceuticals's Operating Margin % or its related term are showing as below:
NSE:SENORES'
s Operating Margin % Range Over the Past 10 Years
Min: 8.86 Med: 18.3 Max: 30.84
Current: 24.68
NSE:SENORES's Operating Margin % is ranked better than 89.74% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs NSE:SENORES: 24.68
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Senores Pharmaceuticals Operating Margin % Related Terms
Senores Pharmaceuticals Operating Margin % Historical Data
* Premium members only.
The historical data trend for Senores Pharmaceuticals's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SENORES vs LLY, JNJ, ABBV: Operating Margin % Comparison
For the Drug Manufacturers - General subindustry, Senores Pharmaceuticals's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senores Pharmaceuticals Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Senores Pharmaceuticals's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Senores Pharmaceuticals's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Senores Pharmaceuticals's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senores Pharmaceuticals (NSE:SENORES) has a Operating Margin % of 21.80% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Senores Pharmaceuticals and its competitors. This is 19% above median its historical median of 18.30. Over the past decade, Senores Pharmaceuticals' Operating Margin % has ranged from 8.86 to 30.84. According to the industry distribution chart, Senores Pharmaceuticals ranks #98 out of 955 companies in the Drug Manufacturers industry, placing it in the top 10.3%.
Is Senores Pharmaceuticals' Operating Margin % too high?
Senores Pharmaceuticals' current Operating Margin % of 21.80% is 19% above median its 10-year median of 18.30. Over the past 10 years, this metric has ranged from a low of 8.86 to a high of 30.84. The Drug Manufacturers industry median Operating Margin % is 7.45. Senores Pharmaceuticals' value of 21.80% is 192.6% above this industry median. Based on the distribution chart, Senores Pharmaceuticals ranks #98 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Senores Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' Operating Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Senores Pharmaceuticals ranks #98 out of 955 companies for Operating Margin %. This places Senores Pharmaceuticals in the top 10% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. Senores Pharmaceuticals' value of 21.80% is 192.6% above this benchmark. Historically, Senores Pharmaceuticals' own Operating Margin % has ranged from 8.86 to 30.84 over the past decade. While the company's 10-year median is 18.30 vs. the industry median of 7.45, Senores Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senores Pharmaceuticals's current Operating Margin % of 21.80% is 192.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Senores Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senores Pharmaceuticals's current Operating Margin % is 21.80%, which is 19% above median its own 10-year median of 18.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current Operating Margin % of 21.80%. The current Operating Margin % is 21.80%, which is 19% above median its 10-year median of 18.30 and 192.6% above the Drug Manufacturers industry median of 7.45. Senores Pharmaceuticals' overall GF Score™ is 18/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current Operating Margin % is 21.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
18GF Score
Get the complete analysis for NSE:SENORES
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SENORES has been successfully added to your 
